Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
SOPHiA GENETICS (SOPH)
NASDAQ:SOPH
Holding SOPH?
Track your performance easily
SOPH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.70 - $7.37
Previous Close$3.6
Volume16.29K
Average Volume (3M)50.98K
Market Cap
$235.35M
Enterprise Value$117.16M
Total Cash (Recent Filing)$121.12M
Total Debt (Recent Filing)$2.93M
Price to Earnings (P/E)―
Beta1.67
Next Earnings
Nov 05, 2024EPS Estimate
-$0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.02
Shares Outstanding65,230,559
10 Day Avg. Volume14,902
30 Day Avg. Volume50,983
Standard Deviation0.24
R-Squared0.05
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)1.55
Price to Sales (P/S)3.77
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.03
Enterprise Value/Gross Profit2.73
Enterprise Value/Ebitda-2.61
Forecast
1Y Price Target
$6.00Price Target Upside66.67% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
SOPHiA GENETICS News
PremiumCompany Announcements
SOPHiA GENETICS Q3 2024 Financial Highlights
PremiumCompany Announcements
SOPHiA GENETICS Faces Financial Challenges Amid Losses
PremiumCompany Announcements
SOPHiA GENETICS Announces Key Leadership AppointmentsPremiumPre-Earnings
Is SOPH a Buy, Before Earnings?Bulls Say, Bears Say
Bulls Say
Business ModelAn inherently higher margin business model and a healthy balance sheet should provide downside support, particularly given undemanding valuation.
Management OutlookManagement believes current headwinds are transitory, and the underlying drivers (new customer adds, pharma pipeline, utilization trends) all remain positive.
Market PotentialAnalyst's recommendation is supported by the differentiated business model, large under-penetrated market, upside drivers (long-term) and a solid balance sheet.
Bears Say
Guidance RevisionManagement reduced its fiscal year guidance by approximately 17%, with a notable 60% of this decrease attributed to challenges in the pharmaceutical sector for the second half of the year.
Market ChallengesRevenue faced negative impacts from macroeconomic headwinds in the Biopharma sector and the EMEA region.
Revenue PerformanceThe company's revenue of $15.8 million fell significantly short of expectations, which were set at $17.8 million by analysts and $17.4 million by consensus.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.93% Mutual Funds
6.38% Other Institutional Investors
92.61% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
The estimated number of people who visited one or more of the websites owned by SOPHiA GENETICS
Desktop Users
Mobile Users
SOPH FAQ
What was SOPHiA GENETICS’s price range in the past 12 months?
SOPHiA GENETICS lowest stock price was $2.70 and its highest was $7.37 in the past 12 months.
What is SOPHiA GENETICS’s market cap?
Currently, no data Available
When is SOPHiA GENETICS’s upcoming earnings report date?
SOPHiA GENETICS’s upcoming earnings report date is Nov 05, 2024 which is 5 days ago.
How were SOPHiA GENETICS’s earnings last quarter?
SOPHiA GENETICS released its earnings results on Aug 06, 2024. The company reported -$0.23 earnings per share for the quarter, beating the consensus estimate of -$0.266 by $0.036.
Is SOPHiA GENETICS overvalued?
According to Wall Street analysts SOPHiA GENETICS’s price is currently Undervalued.
Does SOPHiA GENETICS pay dividends?
SOPHiA GENETICS does not currently pay dividends.
What is SOPHiA GENETICS’s EPS estimate?
SOPHiA GENETICS’s EPS estimate is -$0.22.
How many shares outstanding does SOPHiA GENETICS have?
SOPHiA GENETICS has 65,375,090 shares outstanding.
What happened to SOPHiA GENETICS’s price movement after its last earnings report?
SOPHiA GENETICS reported an EPS of -$0.23 in its last earnings report, beating expectations of -$0.266. Following the earnings report the stock price went down -2.169%.
Which hedge fund is a major shareholder of SOPHiA GENETICS?
Among the largest hedge funds holding SOPHiA GENETICS’s share is Generation Investment Management LLP. It holds SOPHiA GENETICS’s shares valued at 31M.
---
SOPHiA GENETICS Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.00 (66.67% Upside)
$6.00 (66.67% Upside)
Blogger Sentiment
Neutral
SOPH Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.9M Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-1.90%
12-Months-Change
Fundamentals
Return on Equity
-45.56%
Trailing 12-Months
Asset Growth
-18.86%
Trailing 12-Months
Company Description
SOPHiA GENETICS
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities.
---
SOPH Company Deck
---
SOPH Earnings Call
Q2 2024
0:00 / 0:00
---
SOPH Stock 12 Month Forecast
Average Price Target
$6.00
▲(66.67% Upside)
Technical Analysis
Best Analysts Covering SOPH
1 Year
1 Year Success Rate
4/9 ratings generated profit
1 Year Average Return
+14.21%
reiterated a buy rating 3 months ago
Copying Mark Massaro's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of +14.21% per trade.
---